2004
DOI: 10.1182/blood-2004-01-0360
|View full text |Cite
|
Sign up to set email alerts
|

Adenovirus-mediated intralesional interferon-γ gene transfer induces tumor regressions in cutaneous lymphomas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
66
0
2

Year Published

2005
2005
2016
2016

Publication Types

Select...
7
2
1

Relationship

1
9

Authors

Journals

citations
Cited by 97 publications
(69 citation statements)
references
References 31 publications
0
66
0
2
Order By: Relevance
“…However, RRMs can have a structural role in proteinprotein interactions independent of RNA binding (Fribourg et al 2003), so we cannot determine the molecular function of Swm and its homologs by genetic methods alone. We are intrigued by the fact that the other vertebrate homolog, RBM-26, was identified as se70-2, an autoantigen that is recognized by sera of cutaneous T-cell lymphoma patients and has been used as a diagnostic marker for this tumor (Eichmuller et al 2001;Dummer et al 2004). In addition, the mouse RBM-26/se70-2 locus was identified as one of four genes deleted in a region required for normal murine skeletal, cartilage, and craniofacial development (Peterson et al 2002).…”
Section: Discussionmentioning
confidence: 99%
“…However, RRMs can have a structural role in proteinprotein interactions independent of RNA binding (Fribourg et al 2003), so we cannot determine the molecular function of Swm and its homologs by genetic methods alone. We are intrigued by the fact that the other vertebrate homolog, RBM-26, was identified as se70-2, an autoantigen that is recognized by sera of cutaneous T-cell lymphoma patients and has been used as a diagnostic marker for this tumor (Eichmuller et al 2001;Dummer et al 2004). In addition, the mouse RBM-26/se70-2 locus was identified as one of four genes deleted in a region required for normal murine skeletal, cartilage, and craniofacial development (Peterson et al 2002).…”
Section: Discussionmentioning
confidence: 99%
“…The use of recombinant cytokines has found its rationale in the immunobiology of this disease group and aims to enhance antitumor immunity (1,2). As an alternative to recombinant cytokines that are often associated with significant systemic side effects, we recently described adenovirusmediated (Ad-mediated) delivery of human IFN-γ gene directly into CL lesions, showing good tolerability together with promising efficacy (3). Adenoviral vectors belong to the most frequently used gene delivery systems due to their ability to transduce a broad spectrum of cells and package large sequences and their low production costs (4).…”
Section: Introductionmentioning
confidence: 99%
“…[5][6][7][8][9][10][11][12][13][14][15][16] Much evidence supports that malignant T cells drive the immune dysregulation to impede antitumor immunity and that suppression of the patient's cellular immunity is associated with increased disease activity. [17][18][19][20][21][22] Two factors that seem to hold a central position in driving the immune dysregulation are signal transducer and activator of transcription 3 (Stat3) and the immunoregulatory cytokine interleukin-10 (IL-10). In keeping, the malignant activity of Stat3 and the expression of IL-10 increase during disease progression in parallel with the evolving immune dysregulation.…”
Section: Introductionmentioning
confidence: 99%